Trial
NCT00600301
Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Asociación para Evitar la Ceguera en México
Collaborators
—
Condition
Diffuse Diabetic Macular Edema
Intervention
Triamcinolone Acetonide and Bevacizumab
Why stopped
undefined
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-30